Laurence Sperling is a Cardiology physician affiliated with Emory University. OpenAlex indexes 520 publications with 32,332 citations (h-index 68); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.8%Statin25.1%Atorvastatin Calcium50%Rosuvastatin Calcium34%Pravastatin Sodium12%Simvastatin5%Part D<11 patientsBeta blocker17.3%Carvedilol46%Metoprolol Succinate36%Metoprolol Tartrate18%Part D≥46 patients+ 11 more classes in this area
Blood & clotting
10.2%Factor Xa inhibitor7.4%Eliquis100%Part D≥37 patientsP2Y12 inhibitor2.8%Clopidogrel100%Part D≥20 patientsMetabolism & gastrointestinal
2%Potassium supplement1.1%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor1%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
Edwin Horwitz, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”